Información del producto
- 4H-1-Benzopyran-2-carboxylicacid,7-[[(1S,2E,4Z)-9-(4-acetyl-3-hydroxy-2-propylphenoxy)-1-[(R)-hydroxy[3-(trifluoromethyl)phenyl]methyl]-2,4-nonadienyl]thio]-4-oxo-(9CI)
- 4H-1-Benzopyran-2-carboxylic acid, 7-[[9-(4-acetyl-3-hydroxy-2-propylphenoxy)-1-[hydroxy[3-(trifluoromethyl)phenyl]methyl]-2,4-nonadienyl]thio]-4-oxo-,[S-[R*,S*-(E,Z)]]-
Iralukast is a leukotriene receptor antagonist that blocks the bronchoconstrictor response. It is used in the treatment of bronchial asthma, chronic obstructive pulmonary disease, and bowel diseases such as ulcerative colitis. Iralukast is not absorbed into the bloodstream and therefore does not inhibit the production of the inflammatory mediators that are responsible for these diseases. Iralukast binds to receptors on cells lining the airways, preventing activation of cells by leukotrienes, which are released by mast cells in response to an allergen or irritant. This binding prevents the release of inflammatory mediators from mast cells and reduces bronchial reactivity. Iralukast also has been shown to inhibit the enzyme activity of phospholipase A2 (PLA2), which has been implicated in inflammatory bowel disease.
Propiedades químicas
Consulta técnica sobre: 3D-FA104085 Iralukast
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
